HYUGA PRIMARY CARE will repurchase its own shares at ¥1,718 each in a tender running from 18 November to 16 December, the second stage of the management buyout that JG44 launched at ¥2,110 a share. The board resolved on 17 November to proceed after JG44's offer drew applications for 3,864,488 shares, a count that includes shares deliverable on exercise of share options (52.03% on the company's share base). That cleared the 1,518,400-share minimum, the condition for the self-tender.
Who is expected to sell
The target is the M3 group (CUC, M3 and M3 Career), which holds 2,040,000 shares (27.47%). The company expects 646,928 of them (8.71%) to be tendered. It set the purchase ceiling higher, at 711,621 shares (9.58%), for up to ¥1.22bn, in case other holders prefer this route. If applications exceed the cap, the company buys pro rata. Funding comes from private bonds taken up by JG44 plus the company's own cash, and settlement starts on 12 January 2027.
Why the price is ¥392 lower
The company says corporate shareholders can exclude deemed dividends from taxable income. The ¥1,718 price is set so that the M3 group's after-tax proceeds do not exceed what it would have received tendering at ¥2,110, so it gains no more than ordinary shareholders who tendered. JG44 expected ordinary holders to use the first offer, not this one.
The price is below the market. It is a 17.52% discount to the ¥2,083 close on 16 November, though a 20.90% premium to the six-month average close of ¥1,421.
What comes next
The founder-president sold 864,128 shares (11.63%) into the first tender and keeps 493,072 (6.64%), the sixth-largest holding. His asset-management vehicle, a general incorporated association, holds another 900,000 (12.12%). The release lists the following steps, all planned:
- An extraordinary shareholders' meeting on 6 January 2027, with a record date of 18 November.
- Stock lending among the non-tendering holders and a share consolidation in early February 2027.
- A share split and a further buyback in early March, and a share exchange in early April.
After the exchange, voting rights in JG44 are expected to be split as follows: JGIA Fund 22.60%, two Cayman funds 10.33% each, the president 10.55%, his association 19.25% and the M3 group 26.93%. The exchange ratio is not yet set, and the president's management agreement has no signing date or terms. The release says consolidation leads to delisting under Tokyo Stock Exchange rules.
Two filings add detail on security and share counts. The M3 filing dated 17 November reports agreements signed on 12 November to give Fukuoka Bank and Mizuho Bank first-ranking pledges over the shares its holders will not tender, as security for JG44's term loan. The president's own filing says he signed an agreement on 12 November to provide all his shares as collateral for JG44's borrowings from the same banks.
Ownership percentages differ by source. The company release divides by 7,427,044 shares, which includes unexercised stock options, and puts JG44 at 52.03%. M3's large-shareholding report uses 7,327,600 shares plus 246,000 option shares, and shows JG44 at 51.03%.
